Author

Jennifer D. Hamilton 1

1 Regeneron Pharmaceuticals, Inc.,Tarrytown,United States of America

DUPILUMAB EFFICACY AND SAFETY IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PART A OF A RANDOMIZED, PLACEBO-CONTROLLED THREE-PART, PHASE 3 STUDY

Evan S Dellon, Marc E. Rothenberg, Margaret H. Collins, Ikuo Hirano, Mirna Chehade, Arjan Bredenoord, Alfredo J. Lucendo, Jonathan Spergel, Qiong Zhao, Jennifer D. Hamilton, Bethany Beazley, Isabelle Guillemin, Siddhesh Kamat, Leda Mannent, Marcella Ruddy, Elizabeth Laws, Bolanle Akinlade, Nikhil Amin, Allen Radin, Brad

DUPILUMAB EFFICACY AND SAFETY IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC OESOPHAGITIS: A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 TRIAL

Ikuo Hirano, Evan S Dellon, Jennifer D. Hamilton, Margaret H. Collins, Kathryn Peterson, Mirna Chehade, Alain Schoepfer, Ekaterina Safroneeva, Marc E. Rothenberg, Gary W. Falk, Yehudith Assouline Dayan, Zhizhi Qing, Brian N. Swanson, Gianluca Pirozzi, Leda Mannent, Neil MH Graham, Bolanle Akinlade, Allen Radin

DUPILUMAB NORMALIZES EXPRESSION OF GENES ASSOCIATED WITH TYPE 2 INFLAMMATION IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Jennifer D. Hamilton, Margaret H. Collins, Wei Keat Lim, Sara Hamon, Matthew F. Wipperman, Allen Radin, Mirna Chehade, Ikuo Hirano, Evan S Dellon, Sivan Harel, William Brian, Leda Mannent, Marc E. Rothenberg

DUPILUMAB NORMALIZES EXPRESSION OF GENES ASSOCIATED WITH TYPE 2 INFLAMMATION IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Jennifer D. Hamilton

THE GENE EXPRESSION SIGNATURE MODULATED BY DUPILUMAB IS HIGHLY CORRELATED WITH EOSINOPHILIC ESOPHAGITIS HISTOLOGICAL SEVERITY

Margaret H. Collins, Jennifer D. Hamilton, Wei Keat Lim, Sara Hamon, Matthew F. Wipperman, Allen Radin, Mirna Chehade, Ikuo Hirano, Evan S Dellon, Sivan Harel, William Brian, Leda Mannent, Marc E. Rothenberg

Item 1 - 5 / 5
1